Follow-up Study of SyB L-0501 in Combination With Rituximab to Treat DLBCL

NCT04354402 · clinicaltrials.gov ↗

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

OTHER: No intervention

Sponsor

SymBio Pharmaceuticals